MGI RAISES $16.5 MILLION IN OFFERING

MGI Pharma Inc., which acquires and develops therapeutics forcancer and other diseases, on Friday said it completed a 2million-share secondary offering of common stock priced at$8.25, raising $16.5 million. Stock in the Minneapolis-basedcompany (NASDAQ:MOGN) closed at $8.38, down 13 cents, onFriday.

(c) 1997 American Health Consultants. All rights reserved.